Indole-3-propionic acid protects medium-diversity colitic mice via barrier enhancement preferentially over anti-inflammatory effects
American Journal of Physiology-Gastrointestinal and Liver Physiology · 2025
DOI: 10.1152/ajpgi.00256.2024 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Gastrointestinal and Liver Physiology, 2025. Verfasst von Kristoff M Nieves und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology & Pharmacology, University of Calgary, Calgary, Alberta, Canada. Hauptthemen laut MEDLINE: Indoles, Colitis, Gastrointestinal Microbiome, Intestinal Mucosa. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Crohn's and Colitis Canada (Crohn et Colite Canada), Crohn's and Colitis Foundation (CCF), U.S. Department of Defense (DOD).
Abstract (Originalsprache)
Indole-3-propionic acid (IPA) is a metabolite produced by the intestinal microbiota that has been shown to elicit beneficial effects in the gastrointestinal (GI) tract that include regulating intestinal barrier function, reducing inflammation, and controlling immune responses that lead to fibrosis. In patients with inflammatory bowel disease (IBD), IPA levels are reduced. In the current study, we found that treating mice with IPA at the peak of intestinal inflammation improved clinical outcomes and disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology & Pharmacology, University of Calgary, Calgary, Alberta, Canada.
- Snyder Institute for Chronic Diseases, University of Calgary, Calgary, Alberta, Canada.
- Department of Critical Care Medicine, University of Calgary, Calgary, Alberta, Canada.
- Faculty of Veterinary Medicine, University of Calgary, Calgary, Alberta, Canada.
- Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
- Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, Alberta, Canada.
ORCID-Profile: Matthew Stephens, Andrew J Thorne, Kathryn Strayer, Darasimi Kola-Ilesanmi, Simon A Hirota
Förderung
- Crohn's and Colitis Canada (Crohn et Colite Canada)
- Crohn's and Colitis Foundation (CCF)
- U.S. Department of Defense (DOD)
- Canadian Government | CIHR | Canadian Institutes of Health Research - Antimicrobial Resistance Research Initiative (AMR)
- NCI NIH HHS
- HHS | NIH | NIDDK | Division of Diabetes, Endocrinology, and Metabolic Diseases (DEM)
Zitieren
APA
Nieves, K. M., Flannigan, K. L., Hughes, E., Stephens, M., Thorne, A. J., Delanne-Cuménal, A., Strayer, K., Kola-Ilesanmi, D., Wickramasinghe, S., Mirzadzar, N., Baruta, G., McDonald, B., Cobo, E. R., Petri, B., Mani, S., & Hirota, S. A. (2025). Indole-3-propionic acid protects medium-diversity colitic mice via barrier enhancement preferentially over anti-inflammatory effects. American Journal of Physiology-Gastrointestinal and Liver Physiology. https://doi.org/10.1152/ajpgi.00256.2024
Vancouver
Nieves KM, Flannigan KL, Hughes E, Stephens M, Thorne AJ, Delanne-Cuménal A, et al. Indole-3-propionic acid protects medium-diversity colitic mice via barrier enhancement preferentially over anti-inflammatory effects. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2025. doi:10.1152/ajpgi.00256.2024
BibTeX
@article{Nieves2025,
author = {Nieves, Kristoff M and Flannigan, Kyle L and Hughes, Elizabeth and Stephens, Matthew and Thorne, Andrew J and Delanne-Cuménal, Ameline and Strayer, Kathryn and Kola-Ilesanmi, Darasimi and Wickramasinghe, Senya and Mirzadzar, Niloofar and Baruta, Grace and McDonald, Braedon and Cobo, Eduardo R and Petri, Björn and Mani, Sridhar and Hirota, Simon A},
title = {Indole-3-propionic acid protects medium-diversity colitic mice via barrier enhancement preferentially over anti-inflammatory effects},
journal = {American Journal of Physiology-Gastrointestinal and Liver Physiology},
year = {2025},
doi = {10.1152/ajpgi.00256.2024}
}
EUVIMED